Dysregulation of REV-ERBα impairs GABAergic function and promotes epileptic seizures in preclinical models

Tianpeng Zhang1,2,3, Fangjun Yu2, Haiman Xu2

  • 1Institute of Molecular Rhythm and Metabolism, Guangzhou University of Chinese Medicine, Guangzhou, China.

Nature Communications
|February 23, 2021
PubMed

Insights

Rev-erbα (a protein) is upregulated in epilepsy and regulates seizure severity. Modulating Rev-erbα impacts seizure susceptibility and synaptic function, offering new therapeutic targets for epilepsy.

Area of Science:

  • Neuroscience
  • Chronobiology
  • Molecular Biology

Background:

  • Epilepsy mechanisms require further elucidation for improved therapies.
  • Circadian rhythms influence physiological processes, potentially impacting neurological disorders.

Purpose of the Study:

  • To investigate the role of Rev-erbα in the circadian regulation of epileptic seizures.
  • To explore Rev-erbα's impact on synaptic function and GABAergic signaling in epilepsy.

Main Methods:

  • Analysis of Rev-erbα expression in human epilepsy brain tissues and a mouse model.
  • In vivo studies involving Rev-erbα ablation or pharmacological modulation in mice.
  • Electrophysiological recordings in the mouse hippocampus to assess synaptic currents.
  • Identification of GABA transporters regulated by Rev-erbα.

Main Results:

  • Rev-erbα is upregulated in epilepsy and its modulation affects seizure susceptibility and diurnal seizure patterns.
  • Rev-erbα manipulation alters inhibitory postsynaptic currents and GABAergic signaling in the hippocampus.
  • Slc6a1 and Slc6a11 transporters are identified as Rev-erbα-regulated mediators of GABA clearance.
  • Rev-erbα influences Slc6a1 and Slc6a11 expression via repression of E4bp4.

Conclusions:

  • Rev-erbα plays a critical role in the circadian control of epilepsy.
  • Rev-erbα modulates synaptic function by regulating GABAergic signaling.
  • Findings suggest Rev-erbα as a potential therapeutic target at the intersection of circadian rhythms and epilepsy.

Related Concept Videos

Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
930
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
603
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
824
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
423
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
683